--- title: Buy Pimecrolimus 1% Cream Tube Online description: Pimecrolimus 1% cream treats eczema and atopic dermatitis. Order this effective topical treatment from our secure online pharmacy. type: product language: en url: https://liabilis.com/order-pimecrolimus-online-en.html availability: in_stock shipping: - type: Standard Airmail price: 10.00 currency: USD area: Worldwide time: 14-21 days - type: Tracked Express price: 30.00 currency: USD area: Worldwide tracking: true time: 5-9 days price_min: 149.99 price_max: 447.99 currency: USD offers: - name: 10g x 2 tubes price: 149.99 - name: 10g x 4 tubes price: 271.99 - name: 30g x 2 tubes price: 239.99 - name: 30g x 4 tubes price: 447.99 --- # Buy Pimecrolimus 1% Cream Tube Online Pimecrolimus is a topical calcineurin inhibitor used to treat eczema and atopic dermatitis. It works by suppressing the immune response that causes skin inflammation and itching. This medication is designed for adults and children over two years who need a non-steroidal treatment option for inflammatory skin conditions. Our pharmacy offers Pimecrolimus in a 1% cream formulation in convenient tubes. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **10g** | 2 tubes | **$149.99** | $75.00 | In Stock | | **10g** | 4 tubes | **$271.99** | $68.00 | In Stock | | **30g** | 2 tubes | **$239.99** | $120.00 | In Stock | | **30g** | 4 tubes | **$447.99** | $112.00 | In Stock | [Buy Now](https://liabilis.com/order-pimecrolimus-online-en.html) ## Introduction Pimecrolimus is a topical calcineurin inhibitor used to manage inflammatory skin conditions, most notably mild to moderate atopic dermatitis. The active ingredient is pimecrolimus, supplied in a 1 % cream that is packaged in a tube for easy topical application. By selectively modulating immune responses in the skin, pimecrolimus reduces redness, itching, and swelling without the skin-thinning effects associated with potent corticosteroids. It is indicated for adult patients who require a non-steroidal option for controlling eczema flares. ## Quick Reference Facts **Active Ingredient** : Pimecrolimus **Form** : Tube, 1 % cream **Primary Uses** : Treatment of mild to moderate atopic dermatitis (eczema) in adults ## What is Pimecrolimus? Pimecrolimus is the generic version of medications containing the active compound pimecrolimus. It belongs to the class of topical calcineurin inhibitors, which act locally to suppress immune activation in the skin. The product is marketed under brand names such as **Elidel** in many countries. Developed by Novartis and approved in the early 200s, the generic formulation offers the same molecular profile as the branded version, meeting regulatory standards for potency, safety, and bioequivalence. Because it is a non-steroidal anti-inflammatory agent, it provides an alternative for patients who cannot tolerate or do not want long-term corticosteroid therapy. ## How Pimecrolimus Works Calcineurin is an enzyme that activates T-cells by dephosphorylating the nuclear factor of activated T-cells (NF-AT). Pimecrolimus binds reversibly to the immunophilin FKBP-12, forming a complex that inhibits calcineurin activity. This blockade prevents the transcription of pro-inflammatory cytokines such as interleukin-2, interferon-γ, and tumor necrosis factor-α within skin-resident immune cells. By reducing cytokine production, pimecrolimus diminishes the recruitment of inflammatory cells to the epidermis, leading to decreased erythema, edema, and pruritus. Topical application limits systemic absorption, so the drug’s effect is largely confined to the treated area. Peak local concentrations are reached within a few hours, and the drug is metabolized by hepatic CYP3A4 after any systemic uptake, yielding a short systemic half-life that minimizes drug-drug interaction risk. ## Conditions Treated with Pimecrolimus - **Atopic dermatitis (eczema)** - Pimecrolimus suppresses the underlying T-cell-driven inflammation, providing relief from itching and skin redness while preserving epidermal barrier integrity. - **Chronic hand eczema** - In cases where corticosteroids cause skin atrophy, pimecrolimus offers anti-inflammatory control without thinning the delicate skin on the hands. - **Mild to moderate facial eczema** - The non-steroidal nature of pimecrolimus makes it suitable for sensitive facial skin, reducing the risk of steroid-induced telangiectasia. *(Only the indications listed above are approved by major regulatory agencies such as the FDA and EMA.)* ## Is Pimecrolimus the Right Medication for You? Pimecrolimus is most appropriate for adults with mild to moderate atopic dermatitis who require a steroid-sparing option, especially on facial or intertriginous areas. It is also favored for patients who have experienced adverse effects from topical corticosteroids or who need long-term maintenance therapy. Contraindications include known hypersensitivity to pimecrolimus or any excipient in the formulation, and the presence of active skin infections (bacterial, viral, or fungal) at the intended application site. Individuals with severely compromised immune systems should use the drug only under specialist supervision, as local immunosuppression could theoretically exacerbate opportunistic infections. ## Buying Pimecrolimus from [our online pharmacy](https://liabilis.com/order-pimecrolimus-online-en.html) ### Why Choose Our Service? Accessing pimecrolimus can be challenging due to cost or limited stock in local pharmacies. [our online pharmacy](https://liabilis.com/order-pimecrolimus-online-en.html) provides a streamlined way to obtain the medication at a price close to the manufacturer’s wholesale cost, helping you stay on therapy without financial strain. ### Quality & Safety Assurance We partner with licensed international pharmacies to ensure quality and authenticity. All products are sourced from reputable manufacturers that comply with Good Manufacturing Practice (GMP) standards, and each shipment is verified by a qualified pharmacist before dispatch. ### Pricing & Access The generic formulation of pimecrolimus is typically 30-45 % less expensive than the branded equivalent, offering substantial savings for long-term users. Our platform also facilitates delivery to regions where the medication may be unavailable or subject to insurance restrictions. ### Discreet Delivery Orders are packaged in unmarked, tamper-evident envelopes and dispatched via express courier within 7 days or standard airmail in approximately 3 weeks. Privacy is maintained throughout the process, and tracking information is provided for every shipment. ## Use: Dosing, Missed Dose, Overdose - **Standard dosing** - Apply a thin layer of the 1 % cream to the affected skin twice daily (morning and evening). The amount should be enough to cover the lesion without excess pooling. - **Missed dose** - If a dose is forgotten, apply it as soon as you remember unless it is near the time of the next scheduled dose; in that case, skip the missed application and resume the regular schedule. Do not double the dose. - **Overdose** - Accidental ingestion or application of a large amount of the cream is unlikely to cause systemic toxicity, but seek medical attention if serious irritation, widespread redness, or systemic symptoms develop. - **Precautions** - Avoid applying the cream to compromised skin (open wounds, infected areas). Do not use on the face if you have a known hypersensitivity. Alcohol and other topical irritants should be avoided concurrently, and patients should refrain from operating heavy machinery if the cream causes significant local discomfort. ## Safety Information ### ⚠️ Who Should Not Take Pimecrolimus - Individuals with a documented allergy to pimecrolimus or any inactive ingredient in the tube. - Patients with active cutaneous infections (e.g., impetigo, herpes simplex, fungal infections) at the intended site of application. - Persons receiving systemic immunosuppressive therapy (e.g., organ transplant recipients) unless specifically advised by a specialist. ### Common Side Effects - **Burning or stinging sensation** - Reported in up to 20 % of users, usually transient and diminishing with continued use. - **Mild itching or erythema** - Typically mild and resolves within a few days. - **Dryness or scaling of the skin** - Can be managed with non-medicated moisturizers. ### Serious Side Effects (Seek Immediate Medical Help) - **Severe skin infection** - Rapidly expanding redness, pus, or fever may indicate secondary bacterial infection. - **Unexplained rash or blistering** - Could represent a hypersensitivity reaction. - **Signs of systemic immunosuppression** - Persistent fever, unexplained lymphadenopathy, or unusual bruising. If any of these occur, discontinue the medication and contact a healthcare professional promptly. ### Drug & Food Interactions - **Systemic immunosuppressants (e.g., cyclosporine, tacrolimus)** - Topical pimecrolimus may have additive immunosuppressive effects; co-administration should be monitored. - **Photosensitizing agents** - Caution when using topical pimecrolimus together with sun-sensitizing drugs; employ sunscreen and protective clothing. - **Oral CYP3A4 inhibitors (e.g., ketoconazole, erythromycin)** - Because systemic absorption is minimal, clinically significant interactions are rare, but caution is advised in extensive or prolonged use. ## Off-Label and Investigational Uses of Pimecrolimus - **Seborrheic dermatitis** - Small pilot studies have reported improvement in scalp inflammation when pimecrolimus is applied topically, though larger trials are lacking. - **Vitiligo** - Limited case series suggest that pimecrolimus may aid repigmentation when combined with phototherapy, but the evidence remains preliminary. - **Acne rosacea** - Because of its anti-inflammatory properties, some dermatologists have used pimecrolimus off-label for papulopustular rosacea; results are anecdotal. These applications are not approved by regulatory authorities and should only be undertaken under direct supervision of a qualified dermatologist. ## Storage & Handling - **Temperature** - Store at 20 °C ± 5 °C (68 °F ± 9 °F). Do not freeze. - **Light & humidity** - Keep the tube in its original container, protected from excessive light and moisture. - **Expiry** - Use until the printed expiration date; discard any product that changes color, consistency, or develops an unusual odor. - **Disposal** - If no longer needed, discard the empty tube and any remaining cream according to local pharmaceutical waste regulations. ## Frequently Asked Questions **Practical Use & Lifestyle** - **Can I swim or shower after applying pimecrolimus?** The cream should be allowed to absorb for at least 30 minutes before water exposure. Swimming or prolonged showering within this period may reduce efficacy. - **Is it safe to use pimecrolimus while pregnant or breastfeeding?** Current data are limited; the product is classified as pregnancy category C in the United States. Discuss potential risks with your healthcare provider before use. - **Will sunscreen interfere with pimecrolimus?** Broad-spectrum sunscreen can be applied after the cream has dried. It does not diminish the anti-inflammatory effect and helps protect sensitive skin from UV-induced irritation. **Product & Formulation Details** - **What does the pimecrolimus tube look like?** The generic tube is opaque white, bearing the concentration “1 %” on the label and a tamper-evident seal. Appearance may vary slightly by manufacturer. - **Are there any preservatives in the formulation?** The cream contains a small amount of parabens as a preservative, along with typical excipients such as glycerin and cetyl-stearyl alcohol. **Regulatory & Safety Nuances** - **Can pimecrolimus be detected in sport drug tests?** Topical pimecrolimus results in negligible systemic levels and is not listed on standard anti-doping panels. - **Do any countries restrict personal import of pimecrolimus?** Some jurisdictions require a prescription for importation of topical calcineurin inhibitors. Review local customs regulations before ordering. **Scientific & Clinical Curiosity** - **When was pimecrolimus first approved for clinical use?** The medication received its first regulatory approval in the early 200s (2001 in the European Union, 2001 in the United States). - **How does pimecrolimus differ from tacrolimus ointment?** Both inhibit calcineurin, but pimecrolimus has a higher affinity for epidermal keratinocytes and a larger molecular size, which may limit deeper dermal penetration and reduce systemic exposure compared with tacrolimus. ## Glossary **Calcineurin** : An intracellular enzyme that activates T-cells by dephosphorylating NF-AT, leading to cytokine production. **Bioequivalence** : Demonstration that a generic product delivers the same amount of active ingredient into the bloodstream as the reference brand under similar conditions. **FKBP-12** : A small intracellular protein that forms a complex with pimecrolimus, enabling inhibition of calcineurin. **Eczematous dermatitis** : A skin disorder characterized by inflammation, itching, and a disrupted barrier, commonly referred to as eczema. ## Disclaimer The information presented about **Pimecrolimus** is intended for general educational purposes only and does not replace personalized medical counsel. Treatment choices, including any off-label applications, must be made under the guidance of a qualified healthcare professional. Readers are presumed to be competent adults capable of informed health decisions. Our pharmacy service provides a means to obtain Pimecrolimus for individuals who encounter limited availability, insurance constraints, or seek cost-effective generic alternatives. Always discuss initiation, modification, or discontinuation of any medication with your doctor.